Ring 1
Ring 2
Ring 3
Ring 4


Financing Round

  • Series A
Round Led by Symbiosis

Developer of a tissue-based approach designed to advance insights for inflammatory diseases. Evommune develops transformative medicines to advance insights and accelerate the development of medicines. The company has built a robust pipeline of unique therapies with the potential to help patients with chronic inflammatory diseases.

enterome View Website


  • Small Molecule


  • Dermatology
  • Immunology

Development Status

  • Phase 1

Learn More About Evommune